Education
About Us
Working with TipRanks
Follow Us
Genes Tech Group Holdings Company Limited (HK:8257)
:8257
RESEARCH TOOLSreports
Total Valuation
Genes Tech Group Holdings Company Limited has a market cap or net worth of HK$70.00M. The enterprise value is HK$193.87M.
Market CapHK$70.00M
Enterprise ValueHK$193.87M
Share Statistics
Genes Tech Group Holdings Company Limited has 1,000,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,000,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genes Tech Group Holdings Company Limited’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.57%.
Return on Equity (ROE)0.03
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.57%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee3.58M
Profits Per Employee354.83K
Employee Count260
Asset Turnover0.38
Inventory Turnover0.50
Valuation Ratios
The current PE Ratio of Genes Tech Group Holdings Company Limited is 11.7. Genes Tech Group Holdings Company Limited’s PEG ratio is ―.
PE Ratio11.7
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.48
Price to FCF0.00
Price to Operating Cash Flow-21.97
PEG Ratio―
Income Statement
In the last 12 months, Genes Tech Group Holdings Company Limited had revenue of 931.96M and earned 24.28M in profits. Earnings per share was 0.02.
Revenue931.96M
Gross Profit263.33M
Operating Income85.75M
Pretax Income92.25M
Net Income24.28M
EBITDA152.99M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was -11.60M and capital expenditures -965.00K, giving a free cash flow of -12.57M billion.
Operating Cash Flow-11.60M
Free Cash Flow-12.57M
Free Cash Flow per Share-0.01
Dividends & Yields
Genes Tech Group Holdings Company Limited pays an annual dividend of HK$0.012, resulting in a dividend yield of ―
Dividend Per ShareHK$0.012
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.37
52-Week Price Change40.00%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)44.63
Average Volume (3m)153.33K
Important Dates
Genes Tech Group Holdings Company Limited upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateJun 30, 2021
Financial Position
Genes Tech Group Holdings Company Limited as a current ratio of 1.34, with Debt / Equity ratio of 75.57%
Current Ratio1.34
Quick Ratio0.44
Debt to Market Cap1.51
Net Debt to EBITDA2.78
Interest Coverage Ratio4.59
Taxes
In the past 12 months, Genes Tech Group Holdings Company Limited has paid 67.97M in taxes.
Income Tax67.97M
Effective Tax Rate0.74
Enterprise Valuation
Genes Tech Group Holdings Company Limited EV to EBITDA ratio is 5.35, with an EV/FCF ratio of 8.98.
EV to Sales0.88
EV to EBITDA5.35
EV to Free Cash Flow8.98
EV to Operating Cash Flow8.66
Balance Sheet
Genes Tech Group Holdings Company Limited has HK$119.08M in cash and marketable securities with HK$644.21M in debt, giving a net cash position of HK$525.13M billion.
Cash & Marketable SecuritiesHK$119.08M
Total DebtHK$644.21M
Net CashHK$525.13M
Net Cash Per ShareHK$0.53
Tangible Book Value Per ShareHK$0.74
Margins
Gross margin is 28.87%, with operating margin of 9.20%, and net profit margin of 2.61%.
Gross Margin28.87%
Operating Margin9.20%
Pretax Margin9.90%
Net Profit Margin2.61%
EBITDA Margin16.42%
EBIT Margin11.90%
Analyst Forecast
The average price target for Genes Tech Group Holdings Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-32.47%
EPS Growth Forecast-74.03%